1.53
price up icon2.68%   0.04
after-market Handel nachbörslich: 1.53
loading
Schlusskurs vom Vortag:
$1.49
Offen:
$1.53
24-Stunden-Volumen:
722.21K
Relative Volume:
3.74
Marktkapitalisierung:
$21.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.29M
KGV:
-2.5932
EPS:
-0.59
Netto-Cashflow:
$-6.47M
1W Leistung:
+3.38%
1M Leistung:
+14.18%
6M Leistung:
-15.93%
1J Leistung:
+41.67%
1-Tages-Spanne:
Value
$1.50
$1.5509
1-Wochen-Bereich:
Value
$1.4201
$1.5509
52-Wochen-Spanne:
Value
$1.0001
$3.59

NanoViricides Inc Stock (NNVC) Company Profile

Name
Firmenname
NanoViricides Inc
Name
Telefon
203-937-6137
Name
Adresse
1 Controls Drive, Shelton, CT
Name
Mitarbeiter
7
Name
Twitter
@nnvcnyse
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NNVC's Discussions on Twitter

Vergleichen Sie NNVC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NNVC
NanoViricides Inc
1.53 21.95M 0 -8.29M -6.47M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
405.27 104.37B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
715.13 78.59B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
628.32 37.57B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.26 31.25B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.51 27.21B 3.30B -501.07M 1.03B -2.1146

NanoViricides Inc Stock (NNVC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2015-02-11 Eingeleitet Midtown Partners Strong Buy

NanoViricides Inc Aktie (NNVC) Neueste Nachrichten

pulisher
08:43 AM

NanoViricides sees NV-387 as a key defense against bird flu pandemic - Proactive Investors USA

08:43 AM
pulisher
06:32 AM

NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape - Oil City Derrick

06:32 AM
pulisher
06:30 AM

NanoViricides' NV-387 Shows Breakthrough 88% Survival Rate Against H5N1 Bird Flu in Key Study - StockTitan

06:30 AM
pulisher
Dec 09, 2024

NanoViricides CEO highlights urgency of H5N1 preparedness as cases rise in North America By Proactive Investors - Investing.com UK

Dec 09, 2024
pulisher
Dec 06, 2024

NanoViricides CEO highlights urgency of H5N1 preparedness as cases rise in North America - Proactive Investors UK

Dec 06, 2024
pulisher
Nov 29, 2024

NanoViricides: Pioneering the Future of Antiviral Therapies - TechBullion

Nov 29, 2024
pulisher
Nov 26, 2024

NanoViricides (AMEX:$NNVC) Leads Innovation In Broad-Spectrum Antiviral Therapies - Barchart

Nov 26, 2024
pulisher
Nov 26, 2024

NanoViricides (AMEX:$NNVC) Leads Innovation in Broad-Spectrum Antiviral Therapies - openPR

Nov 26, 2024
pulisher
Nov 20, 2024

NanoViricides (NYSE:NNVC) Rating Lowered to “Sell” at StockNews.com - Defense World

Nov 20, 2024
pulisher
Nov 16, 2024

NanoViricides pushes NV-387 to Phase II trials - Proactive Investors Australia

Nov 16, 2024
pulisher
Nov 15, 2024

NanoViricides' Antiviral Drug NV-387 Advances to Phase II Trials Amid Funding Needs - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical TrialMultiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID - Source ONE News

Nov 15, 2024
pulisher
Nov 15, 2024

NanoViricides Inc (NNVC) Quarterly 10-Q Report - Quartz

Nov 15, 2024
pulisher
Nov 15, 2024

NanoViricides pushes NV-387 to Phase II trials | NYSE-A:NNVC - Proactive Investors USA

Nov 15, 2024
pulisher
Nov 14, 2024

NanoViricides: Fiscal Q1 Earnings Snapshot - San Antonio Express-News

Nov 14, 2024
pulisher
Nov 04, 2024

NanoViricides to update on broad-spectrum antiviral drug at Spartan Capital Investors Conference - Proactive Investors Australia

Nov 04, 2024
pulisher
Nov 04, 2024

NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am - Oil City Derrick

Nov 04, 2024
pulisher
Oct 22, 2024

NanoViricides exec to showcase breakthrough antiviral technology at PODD Conference - Proactive financial news

Oct 22, 2024
pulisher
Oct 22, 2024

NanoViricides President Dr. Diwan to Present at the PODD Conference - News-Press Now

Oct 22, 2024
pulisher
Oct 22, 2024

NanoViricides exec to showcase breakthrough antiviral technology at PODD Conference | NYSE-A:NNVC - Proactive Investors USA

Oct 22, 2024
pulisher
Oct 21, 2024

Can NanoViricides Inc (NNVC) Stock Rise to the Top of Healthcare Sector Tuesday? - InvestorsObserver

Oct 21, 2024
pulisher
Oct 20, 2024

Interview with the President and Executive Chairman: NanoViricides, Inc. (NYSEAMERICAN:NNVC) - The Wall Street Transcript

Oct 20, 2024
pulisher
Oct 18, 2024

NNVC - Insider Financial

Oct 18, 2024
pulisher
Oct 16, 2024

Chronic Fatigue Syndrome Market Demand and Opportunities - openPR

Oct 16, 2024
pulisher
Oct 15, 2024

NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology - Oil City Derrick

Oct 15, 2024
pulisher
Oct 14, 2024

Renaissance Technologies LLC Boosts Position in NanoViricides, Inc. (NYSE:NNVC) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

NanoViricides Inc. (NNVC): Best Nanotech Penny Stock to Buy - Insider Monkey

Oct 14, 2024
pulisher
Oct 09, 2024

7 Best Nanotech Penny Stocks to Buy - Insider Monkey

Oct 09, 2024
pulisher
Oct 08, 2024

InvestorNewsBreaks – NanoViricides Inc. (NYSE American: NNVC) to Discuss Its ‘Trojan Horse’ Platform Technology at Upcoming Global AMR Summit - MSN

Oct 08, 2024
pulisher
Oct 08, 2024

Genital Herpes Research and Development Pipeline Market By Application, Size, Share, And Forecast (2024-2034) - Daily News Mirror

Oct 08, 2024
pulisher
Oct 08, 2024

NanoViricides to Present at the Global AMR Summit 2024 Tomorrow - Oil City Derrick

Oct 08, 2024
pulisher
Oct 06, 2024

Apparent Israeli airstrike on mosque in central Gaza kills at least 18 people - Source ONE News

Oct 06, 2024
pulisher
Oct 05, 2024

NanoViricides (NYSE:NNVC) Trading 4.3% Higher – Time to Buy? - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

Marburgvirus Infection Industry value, Share, Technology to (2024-2036) - Daily News Mirror

Oct 04, 2024
pulisher
Sep 30, 2024

Marburgvirus Infection Industry Size, Share, Technology to (2024-2034) - La Funcion mx

Sep 30, 2024
pulisher
Sep 30, 2024

Oasis adds US, Canada and Mexico stops to 2025 tour - Oil City Derrick

Sep 30, 2024
pulisher
Sep 30, 2024

NanoViricides prepares for Phase II trials for antiviral NV-387 - Proactive Investors USA

Sep 30, 2024
pulisher
Sep 30, 2024

No arrests in South Africa mass shootings as death toll rises to 18 - Oil City Derrick

Sep 30, 2024
pulisher
Sep 30, 2024

Over 90,000 Georgia residents sheltering a day after chemical plant fire sends chlorine into the air - Oil City Derrick

Sep 30, 2024
pulisher
Sep 30, 2024

Rwanda reports 8 deaths linked to Ebola-like Marburg virus days after it declared an outbreak - Oil City Derrick

Sep 30, 2024
pulisher
Sep 30, 2024

AT&T exits showbiz, sells remaining stake in DirecTV to private equity firm TPG for $7.6 billion - Oil City Derrick

Sep 30, 2024
pulisher
Sep 30, 2024

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical TrialMultiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID - Source ONE News

Sep 30, 2024
pulisher
Sep 30, 2024

China factory surveys show economy weakening, as Beijing steps up support - Oil City Derrick

Sep 30, 2024
pulisher
Sep 30, 2024

Vance criticized an infrastructure law as a candidate then embraced it as a senator - Oil City Derrick

Sep 30, 2024
pulisher
Sep 27, 2024

NanoViricides, Inc. Reports Earnings Results for the Full Year Ended June 30, 2024 - Marketscreener.com

Sep 27, 2024
pulisher
Sep 27, 2024

POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM) - Oil City Derrick

Sep 27, 2024
pulisher
Sep 26, 2024

Orbán aide faces backlash for saying Hungary wouldn’t have fought a Russian invasion - Oil City Derrick

Sep 26, 2024
pulisher
Sep 26, 2024

The number of Americans filing for jobless aid falls to lowest level in four months - Oil City Derrick

Sep 26, 2024
pulisher
Sep 26, 2024

NanoViricides expands antiviral drug pipeline with TheraCour Pharma agreement - Proactive Investors UK

Sep 26, 2024
pulisher
Sep 26, 2024

Brimma Tech Unveils Advanced AUS Sandbox Solution for Enhanced Mortgage Underwriting - Oil City Derrick

Sep 26, 2024
pulisher
Sep 26, 2024

Harrods apologizes to women who say they were abused by former owner Mohamed Al Fayed - Oil City Derrick

Sep 26, 2024

Finanzdaten der NanoViricides Inc-Aktie (NNVC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$69.84
price up icon 1.45%
$18.67
price up icon 4.48%
$39.59
price up icon 0.51%
$363.65
price up icon 1.13%
$177.70
price up icon 0.68%
$113.51
price up icon 0.38%
Kapitalisierung:     |  Volumen (24h):